Predefined Diets in Patients with Inflammatory Bowel Disease: Systematic Review and Meta-Analysis.
José M ComecheAna Gutierrez-HervasJosé TuellsCesare AltavillaPablo Caballero-PérezPublished in: Nutrients (2020)
Inflammatory bowel disease (IBD) is a chronic disease mediated by the immune system and characterized by the importance of diet in pathological development. This study aims to understand how the use of predefined diets can affect the adult population diagnosed with IBD. We conducted a systematic review and meta-analysis. From the different databases (MEDLINE, Scopus, Cochrane, LILACS, CINAHL, and WOS), we found 4195 registers. After a review process, only 31 research studies were selected for qualitative synthesis and 10 were selected for meta-analysis. The variables used were Crohn's Disease Activity Index (CDAI) for patients with Crohn's Disease (CD) and fecal calprotectin (FC), C-Reactive Protein (CRP), and albumin (ALB) for patients with IBD. Predefined diets have been shown to have partial efficacy for the treatment of IBD and are compatible with other medical treatments. CDAI improved but with reasonable doubts due to the high heterogeneity of the data, while no differences were observed for ALB, FC, and CRP. More studies that evaluate the influence of predefined diets on IBD patients are needed due to the great variability in diets and the tools used to measure their effects.
Keyphrases
- weight loss
- disease activity
- ulcerative colitis
- systematic review
- systemic lupus erythematosus
- rheumatoid arthritis
- case control
- patients with inflammatory bowel disease
- end stage renal disease
- rheumatoid arthritis patients
- ankylosing spondylitis
- ejection fraction
- newly diagnosed
- healthcare
- chronic kidney disease
- juvenile idiopathic arthritis
- randomized controlled trial
- prognostic factors
- single cell
- electronic health record
- deep learning